CLINICAL PRESENTATION OF LEFT VENTRICULAR NONCOMPACTION DIAGNOSED IN ADULTS
Authors:
- Kacper CurzytekKCKacper Curzytek
- Marcelina PodleśnaMPMarcelina Podleśna
- Karol ChromiakKCKarol Chromiak
- Aleksandra StęPieńASAleksandra StęPień
- Kacper BączekKBKacper Bączek
- Kacper BluczakKBKacper Bluczak
- Marta KrzyżanowskaMKMarta Krzyżanowska
- Anna DrużdżelADAnna Drużdżel
- Zuzanna ParfienowiczZPZuzanna Parfienowicz
- Katarzyna CzechowiczKCKatarzyna Czechowicz
Open Access
- 23 March 2026
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (1(49))
Abstract
Left ventricular noncompaction (LVNC) is a rare, morphologically and genetically heterogeneous form of cardiomyopathy, the pathogenesis, classification, and clinical significance of which remain subjects of ongoing debate. The aim of this review is to present the current state of knowledge regarding the classification, pathophysiology, diagnostics, genetic determinants, clinical presentation, and therapeutic management of LVNC. The European Society of Cardiology (ESC) classifies LVNC as an unclassified cardiomyopathy, whereas the American Heart Association (AHA) considers it a genetically determined cardiac disorder. The characteristic morphology arises from abnormal compaction of the left ventricular trabeculae during embryogenesis, although an acquired or adaptive origin of these changes is also possible. Diagnostic evaluation relies primarily on echocardiography and cardiac magnetic resonance imaging; however, the lack of uniform morphological criteria contributes to both overdiagnosis and underdiagnosis. From a genetic perspective, sarcomeric gene mutations predominate and are associated with more severe clinical outcomes. Clinical manifestations include heart failure, arrhythmias, and thromboembolic complications, with reduced left ventricular ejection fraction being the principal prognostic factor. Therapeutic management follows general heart failure treatment strategies, thromboembolism prevention, and implantation of cardiac devices; in advanced cases, heart transplantation or mechanical circulatory support may be considered. An integrated diagnostic approach and the MOGE(S) classification system may serve as a foundation for future standardization.Keywords
This publication has 116 references indexed in Scilit:
- Impairment of Myocardial Perfusion Correlates with Heart Failure Severity in Patients With Non-Compaction CardiomyopathyESC Heart Failure, 2020
- The coexistence of left ventricular non-compaction cardiomyopathy, significant coronary artery disease and massive thrombus formation in left ventricular cavity: A rare case reportJournal of Clinical Ultrasound, 2018
- Left Ventricular Trabeculations in Athletes: Epiphenomenon or Phenotype of Disease?Current Treatment Options in Cardiovascular Medicine, 2018
- Arrhythmias and Conduction Disturbances in Noncompaction Cardiomyopathy2018
- Left Ventricular Non-Compaction in Athletes: To Play or Not to PlaySports Medicine, 2016
- Non-compaction Cardiomyopathy: Prevalence, Prognosis, Pathoetiology, Genetics, and Risk of CardioembolismCurrent Heart Failure Reports, 2014
- Hypertrabeculation vs Left Ventricular Noncompaction on EchocardiogramJAMA Internal Medicine, 2014
- Isolated Left Ventricular Noncompaction in a Newborn With Pierre-Robin SequencePediatric Cardiology, 2012
- Developmental patterning of the myocardiumThe Anatomical Record, 2000
- Identification of a rare congenital anomaly of the myocardium by twodimensional echocardiography: Persistence of isolated myocardial sinusoidsThe American Journal of Cardiology, 1984